Biogenic amines in the colon
References
- Aguilar M.J., Morales-Olivas F.J., Rubio E.: Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro. Br. J. Pharmacol., 1986; 88: 501–506
- Akyuz C., Yasar N.F., Uzun O., Peker K.D., Sunamak O., Duman M., Sehirli A.O., Yol S.: Effects of melatonin on colonic anastomosis healing following chemotherapy in rats. Singapore Med. J., 2018; 59: 545–549
- Auteri M., Zizzo M.G., Amato A., Serio R.: Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. J. Physiol. Biochem., 2016; 73: 395–404
- Barbara G., Cremon C., De Giorgio R., Dothel G., Zecchi L., Bellacosa L., Carini G., Stanghellini V., Corinaldesi R.: Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr. Gastroenterol. Rep., 2011; 13: 308–315
- Barger G., Dale H.H.: Chemical structure and sympathomimetic action of amines. J. Physiol., 1910; 41: 19–59
- Bearcroft C.P., Perrett D., Farthing M.J.: Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: A pilot study. Gut, 1998; 42: 42–46
- Beaulieu J.M., Gainetdinov R.R.: The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev., 2011; 63: 182–217
- Breunig E., Michel K., Zeller F., Seidl S., Weyhern C.W., Schemann M.: Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J. Physiol., 2007; 583: 731–742
- Bubenik G.A.: Thirty four years since the discovery of gastrointestinal melatonin. J. Physiol. Pharmacol., 2008; 59: 33–51
- Bülbring E., Crema A.: Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex. Br. J. Pharmacol. Chemother., 1958; 13: 444–457
- Bülbring E., Crema A.: The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J. Physiol., 1959; 146: 18–28
- Bülbring E., Lin R.C.: The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity. J. Physiol., 1958; 140: 381–407
- Chamanara M., Rashidian A., Mehr S.E., Dehpour A.R., Shirkohi R., Akbarian R., Abdollahi A., Rezayat S.M.: Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: Involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology, 2019; 27: 361–371
- Chen C.Q., Fichna J., Bashashati M., Li Y.Y., Storr M.: Distribution, function and physiological role of melatonin in the lower gut. World J. Gastroenterol., 2011; 17: 3888–3898
- Chen J.X., Pan H., Rothman T.P., Wade P.R., Gershon M.D.: Guinea pig 5-HT transporter: Cloning, expression, distribution, and function in intestinal sensory reception. Am. J. Physiol., 1998; 275: G433–G448
- Chojnacki C., Błasiak J., Fichna J., Chojnacki J., Popławski T.: Evaluation of melatonin secretion and metabolism exponents in patients with ulcerative and lymphocytic colitis. Molecules, 2018; 23: 272
- Chojnacki C., Walecka-Kapica E., Lokieć K., Pawłowicz M., Winczyk K., Chojnacki J., Klupińska G.: Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. Endokrynol. Pol., 2013; 64: 114–120
- Chojnacki C., Wisniewska-Jarosinska M., Walecka-Kapica E., Klupinska G., Jaworek J., Chojnacki J.: Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J. Physiol. Pharmacol., 2011; 62: 327–334
- Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., Crowell M.D., Sharkey K.A., Gershon M.D., Mawe G.M., Moses P.L.: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology, 2004; 126: 1657–1664
- Coates M.D., Tekin I., Vrana K.E., Mawe G.M.: Review article: The many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2017; 46: 569–580
- Costedio M.M., Coates M.D., Danielson A.B., Buttolph T.R.3rd, Blaszyk H.J., Mawe G.M., Hyman N.H.: Serotonin signaling in diverticular disease. J. Gastrointest. Surg., 2008; 12: 1439–1445
- Deiteren A., De Man J.G., Pelckmans P.A., De Winter B.Y.: Histamine H4 receptors in the gastrointestinal tract. Br. J. Pharmacol., 2015; 172: 1165–1178
- Deiteren A., De Man J.G., Ruyssers N.E., Moreels T.G., Pelckmans P.A., De Winter B.Y.: Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. Gut, 2014; 63: 1873–1882
- Dunlop S.P., Coleman N.S., Blackshaw E., Perkins A.C., Singh G., Marsden C.A., Spiller R.C.: Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol., 2005; 3: 349–357
- Dunlop S.P., Jenkins D., Neal K.R., Spiller R.C.: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology, 2003; 125: 1651–1659
- Eisenhofer G., Aneman A., Friberg P., Hooper D., Fåndriks L., Lonroth H., Hunyady B., Mezey E.: Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab., 1997; 82: 3864–3871
- Esteban-Zubero E., López-Pingarrón L., Alatorre-Jimenéz M.A., Ochoa-Moneo P., Buisac-Ramón C., Rivas-Jimenéz M., Castán-Ruiz S., Antoñanzas-Lombarte A., Tan D.X., García J.J., Reiter R.J.: Melatonin’s role as a co-adjuvant treatment in colonic diseases: A review. Life. Sci., 2017; 170: 72–81
- Fabisiak A., Wlodarczyk J., Fabisiak N., Storr M., Fichna J.: Targeting histamine receptors in irritable bowel syndrome: A critical appraisal. J. Neurogastroenterol. Motil., 2017; 23: 341–348
- Fakhfouri G., Rahimian R., Daneshmand A., Bahremand A., Rasouli M.R., Dehpour A.R., Mehr S.E., Mousavizadeh K.: Granisetron ameliorates acetic acid-induced colitis in rats. Hum. Exp. Toxicol., 2010; 29: 321–328
- Fernández-Gil B., Moneim A.E., Ortiz F., Shen Y.Q., Soto-Mercado V., Mendivil-Perez M., Guerra-Librero A., Acuña-Castroviejo D., Molina-Navarro M.M., García-Verdugo J.M., Sayed R.K., Florido J., Luna J.D., López L.C., Escames G.: Melatonin protects rats from radiotherapy-induced small intestine toxicity. PLoS One, 2017; 12: e0174474
- Gershon M.D., Tack J.: The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology, 2007; 132: 397–414
- Ghia J.E., Li N., Wang H., Collins M., Deng Y., El-Sharkawy R.T., Côté F., Mallet J., Khan W.I.: Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology, 2009; 137: 1649–1660
- Greig C.J., Zhang L., Cowles R.A.: Potentiated serotonin signaling in serotonin re-uptake transporter knockout mice increases enterocyte mass and small intestinal absorptive function. Physiol. Rep., 2019; 7: e14278
- Hoffman J.M., Tyler K., MacEachern S.J., Balemba O.B., Johnson A.C., Brooks E.M., Zhao H., Swain G.M., Moses P.L., Galligan J.J., Sharkey K.A., Greenwood-Van Meerveld B., Mawe G.M.: Activation of colonic mucosal 5-HT4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology, 2012; 142: 844–854
- Irving H.R., Tan Y.Y., Tochon-Danguy N., Liu H., Chetty N., Desmond P.V., Pouton C.W., Coupar I.M.: Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life. Sci., 2007; 80: 1198–1205
- Keely S.J., Stack W.A., O’Donoghue D.P., Baird A.W.: Regulation of ion transport by histamine in human colon. Eur. J. Pharmacol., 1995; 279: 203–209
- Kendig D.M., Grider J.R.: Serotonin and colonic motility. Neurogastroenterol. Motil., 2015; 27: 899–905
- Kim D., Kim W., Jeong S., Kim D., Yoo J.W., Jung Y.: Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. Drug Deliv. Transl. Res., 2019; 9: 334–343
- Kim H., Dwyer L., Song J.H., Martin-Cano F.E., Bahney J., Peri L., Britton F.C., Sanders K.M., Koh S.D.: Identification of histamine receptors and effects of histamine on murine and simian colonic excitability. Neurogastroenterol. Motil., 2011; 23: 949–e409
- Kim J.J., Bridle B.W., Ghia J.E., Wang H., Syed S.N., Manocha M.M., Rengasamy P., Shajib M.S., Wan Y., Hedlund P.B., Khan W.I.: Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J. Immunol., 2013; 190: 4795–4804
- Kuhne S., Wijtmans M., Lim H.D., Leurs R., de Esch I.J.: Several down, a few to go: Histamine H3 receptor ligands making the final push towards the market? Expert. Opin. Investig. Drugs, 2011; 20: 1629–1648
- Lanfranchi G.A., Marzio L., Cortini C., Osset E.M.: Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors. Am. J. Dig. Dis., 1978; 23: 257–263
- Li N., Ghia J.E., Wang H., McClemens J., Cote F., Suehiro Y., Mallet J., Khan W.I.: Serotonin activates dendritic cell function in the context of gut inflammation. Am. J. Pathol., 2011; 178: 662–671
- Li Y., Zhang Y., Zhang X.L., Feng X.Y., Liu C.Z., Zhang X.N., Quan Z.S., Yan J.T., Zhu J.X.: Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats. Am. J. Physiol. Cell. Physiol., 2019; 316: C393–C403
- Li Z., Chalazonitis A., Huang Y.Y., Mann J.J., Margolis K.G., Yang Q.M., Kim D.O., Côté F., Mallet J., Gershon M.D.: Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J. Neurosci., 2011; 31: 8998–9009
- Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D.: Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci., 2006; 26: 2798–2807
- Liu C.Z., Zhang X.L., Zhou L., Wang T., Quan Z.S., Zhang Y., Li J., Li G.W., Zheng L.F., Li L.S., Zhu J.X.: Rasagiline, an inhibitor of MAOB, decreases colonic motility through elevating colonic dopamine content. Neurogastroenterol. Motil., 2018; 30: e13390
- Liu M., Geddis M.S., Wen Y., Setlik W., Gershon M.D.: Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol., 2005; 289: G1148–G1163
- Liu M.T., Kuan Y.H., Wang J., Hen R., Gershon M.D.: 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J. Neurosci., 2009; 29: 9683–9699
- Lu W.Z., Gwee K.A., Moochhalla S., Ho K.Y.: Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: A double-blind placebo-controlled study. Aliment. Pharmacol. Ther, 2005; 22: 927–934
- Magro F., Vieira-Coelho M.A., Fraga S., Serrão M.P., Veloso F.T., Ribeiro T., Soares-da-Silva P.: Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig. Dis. Sci., 2002; 47: 216–224
- Margolis K.G., Li Z., Stevanovic K., Saurman V., Israelyan N., Anderson G.M., Snyder I., Veenstra-VanderWeele J., Blakely R.D., Gershon M.D.: Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J. Clin. Invest., 2016; 126: 2221–2235
- Margolis K.G., Stevanovic K., Li Z., Yang Q.M., Oravecz T., Zambrowicz B., Jhaver K.G., Diacou A., Gershon M.D.: Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut, 2014; 63: 928–937
- Martin A.M., Lumsden A.L., Young R.L., Jessup C.F., Spencer N.J., Keating D.J.: Regional differences in nutrient-induced secretion of gut serotonin. Physiol. Rep., 2017; 5: e13199
- Mawe G.M., Hoffman J.M.: Serotonin signalling in the gut – functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 473–486
- Miwa J., Echizen H., Matsueda K., Umeda N.: Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion., 2001; 63: 188–194
- Mousavizadeh K., Rahimian R., Fakhfouri G., Aslani F.S., Ghafourifar P.: Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. Eur. J Clin. Invest., 2009; 39: 375–383
- Riley J.F., West G.B.: Histamine in tissue mast cells. J. Physiol., 1952; 117: 72P–73P
- Saha L., Malhotra S., Rana S., Bhasin D., Pandhi P.: A preliminary study of melatonin in irritable bowel syndrome. J. Clin. Gastroenterol., 2007; 41: 29–32
- Salaga M., Binienda A., Piscitelli F., Mokrowiecka A., Cygankiewicz A.I., Verde R., Malecka-Panas E., Kordek R., Krajewska W.M., Di Marzo V., Fichna J.: Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system. Biochem. Pharmacol., 2019; 161: 37–51
- Sander L.E., Lorentz A., Sellge G., Coëffier M., Neipp M., Veres T., Frieling T., Meier P.N., Manns M.P., Bischoff S.C.: Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut, 2006; 55: 498–504
- Shajib M.S., Chauhan U., Adeeb S., Chetty Y., Armstrong D., Halder S.L.S., Marshall J.K., Khan W.I.: Characterization of serotonin signaling components in patients with inflammatory bowel disease. J. Can. Assoc. Gastroenterol., 2019; 2: 132–140
- Shang B., Shi H., Wang X., Guo X., Wang N., Wang Y., Dong L.: Protective effect of melatonin on myenteric neuron damage in experimental colitis in rats. Fundam. Clin. Pharmacol., 2016; 30: 117–127
- Singaram C., Ashraf W., Gaumnitz E.A., Torbey C., Sengupta A., Pfeiffer R., Quigley E.M.: Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet, 1995; 346: 861–864
- Smith T.K., Dickson E.J., Heredia D.J., Hennig G.W., Bayguinov P.O.: Controversies involving the role of 5-hydroxytryptamine in generating colonic migrating motor complexes: What is spontaneous? Gastroenterology, 2010; 138: 1213–1214
- Söderquist F., Hellström P.M., Cunningham J.L.: Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLoS One, 2015; 10: e0120195
- Song G.H., Leng P.H., Gwee K.A., Moochhala S.M., Ho K.Y.: Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: A randomised, double blind, placebo controlled study. Gut, 2005; 54: 1402–1407
- Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., Neal K.R.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut, 2000; 47: 804–811
- Sullivant A., Mackin A., Pharr T., Cooley J., Wills R., Archer T.: Identification of histamine receptors in the canine gastrointestinal tract. Vet. Immunol. Immunopathol., 2016; 182: 29–36
- Thor P.J., Krolczyk G., Gil K., Zurowski D., Nowak L.: Melatonin and serotonin effects on gastrointestinal motility. J. Physiol. Pharmacol., 2007; 58: 97–103
- Tolstanova G., Deng X., Ahluwalia A., Paunovic B., Prysiazhniuk A., Ostapchenko L., Tarnawski A., Sandor Z., Szabo S.: Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease. Dig. Dis. Sci., 2015; 60: 2963–2975
- Twarog B.M., Page I.H.: Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol., 1953; 175: 157–161
- Vaughan C.J., Aherne A.M., Lane E., Power O., Carey R.M., O’Connell D.P.: Identification and regional distribution of the dopamine D1A receptor in the gastrointestinal tract. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000; 279: R599–R609
- Walker J.K., Gainetdinov R.R., Mangel A.W., Caron M.G., Shetzline M.A.: Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am. J. Physiol. Gastrointest. Liver Physiol., 2000; 279: G311–G318
- Walther D.J., Peter J.U., Bashammakh S., Hörtnagl H., Voits M., Fink H., Bader M.: Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 2003; 299: 76
- Wu H., Liu J., Yin Y., Zhang D., Xia P., Zhu G.: Therapeutic opportunities in colorectal cancer: Focus on melatonin antioncogenic action. Biomed. Res. Int., 2019; 2019: 9740568
- Yaakob N.S., Chinkwo K.A., Chetty N., Coupar I.M., Irving H.R.: Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the human colon. J. Neurogastroenterol. Motil., 2015; 21: 361–369
- Yang Y., Kim W., Kim D., Jeong S., Yoo J.W., Jung Y.: A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model. Drug Des. Dev. Ther., 2018; 13: 231–242
- Zhang X., Guo H., Xu J., Li Y., Li L., Zhang X., Li X., Fan R., Zhang Y., Duan Z., Zhu J.: Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility. Transl. Res., 2012; 159: 407–414
- Zielińska M., Jarmuż A., Sałaga M., Kordek R., Laudon M., Storr M., Fichna J.: Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. Naunyn Schmiedebergs Arch. Pharmacol., 2016; 389: 511–519
- Zizzo M.G., Bellanca A., Amato A., Serio R.: Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon. Neurogastroenterol. Motil., 2020; 32: e13811
DOI: https://doi.org/10.5604/01.3001.0014.7954 | Journal eISSN: 1732-2693
Language: English
Page range: 183 - 190
Submitted on: Feb 2, 2020
Accepted on: Sep 2, 2020
Published on: Mar 11, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2021 Miłosz Jastrzębski, Adam Przybyłkowski, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.